Shelley Chu

Shelley Chu

Directeur/Bestuurslid bij ODYSSEY THERAPEUTICS, INC.

Vermogen: 207 887 $ op 30-06-2026

56 jaar
Health Technology
Finance
Commercial Services

Profiel

Shelley Chu is currently an Independent Director at Odyssey Therapeutics, Inc. since 2025.
Current roles also include Director positions at Alpha-9 Oncology, Inc., Diagonal Therapeutics, Inc., Zag Bio, Inc., SFJ Pharmaceuticals, Inc., Antares Therapeutics, Inc., 3T Biosciences, Inc., ImmunOs Therapeutics AG, Adanate, Inc., Q32 Bio Operations, Inc., Protego Biopharma, Inc., IFM Cinque, Inc., IFM Continua, Inc., IFM Quattro, Inc., TRIANA Biomedicines, Inc., Medikine, Inc., Trishula Therapeutics, Inc., Enlaza Therapeutics, Inc., Ifm Therapeutics, Inc., Abata Therapeutics, Inc., IFM Due, Inc., and Seismic Therapeutic, Inc. since 2022.
A Partner at Lightspeed Management Co LLC since 2020.
Former roles include Director at Kalidex Pharmaceuticals, Inc., Venatorx Pharmaceuticals, Inc., Scorpion Therapeutics, Inc., Tizona Therapeutics, Inc., Phathom Pharmaceuticals, Inc., Novartis Inflammasome Research, Inc., and Partner at Abingworth LLP and Abingworth Management, Inc. Senior Director-R&D Strategy at Gilead Pharmasset LLC from 2012 to 2015.
Independent Director at HilleVax, Inc. from 2021 to 2025.
Principal at Frazier Management LLC and Flagship Pioneering, Inc. from 2002 to 2005.
Education includes undergraduate studies at Princeton University and a doctorate from The University of California, San Francisco.

Bekende belangen in openbare bedrijven

OndernemingDatumAantal aandelenTotale waardeWaarderingsdatum
11-05-2026 11.111 ( 0,02% ) 207 887 $ 30-06-2026

Actieve functies van Shelley Chu

BedrijvenFunctieBegin
ODYSSEY THERAPEUTICS, INC. Directeur/Bestuurslid 01-08-2025
Directeur/Bestuurslid 10-02-2022
Directeur/Bestuurslid -
Directeur/Bestuurslid -
Directeur/Bestuurslid -
Directeur/Bestuurslid -
Directeur/Bestuurslid -
Directeur/Bestuurslid -

Eerdere bekende functies van Shelley Chu

BedrijvenFunctieEinde
HILLEVAX, INC. Directeur/Bestuurslid 17-09-2025
░░░░░░ ░░░░░░░░░░ ░░░ ░░░░░ ░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░░░░░ ░░░░ ░░░░░░░ ░░░░░░ ░░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░ -
░░░░░░░░░░ ░░░░░░░░░░░ ░░░░ ░░░░░░░ ░░░░░░ ░░░░░░░░ -
Ervaring van Shelley Chu in detail bekijken

Opleiding van Shelley Chu

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Connecties

38

Eerstegraads connecties

34

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Verwante bedrijven

Bedrijven in privébezit34

Finance

Health Technology

Health Technology

Finance

Finance

Finance

Consumer Services

Consumer Services

Finance

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Commercial Services

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Technology Services

Health Technology

  1. Beurs
  2. Insiders
  3. Shelley Chu